Filing Flows › iRhythm Holdings (IRTC) › R&D spending
iRhythm Holdings (IRTC) R&D spending by quarter
iRhythm Holdings' R&D spending was $20.6M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 7 quarters it ranged from $19.8M (Q2 2026) to $21.5M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $20.6M | +4% | -2% |
| Q2 2026 | $19.8M | -7% | -6% |
| Q1 2026 | $21.4M | +1% | -0.7% |
| Q4 2025 | $21.0M | +0.1% | — |
| Q3 2025 | $21.0M | +0.1% | — |
| Q2 2025 | $21.0M | -2% | — |
| Q1 2025 | $21.5M | — | — |
Q3 2026 at a glance
iRhythm Holdings, Q3 2026: revenue $222M (+15% year over year), operating margin -14.7%, net loss $29.9M, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is iRhythm Holdings' R&D spending?
iRhythm Holdings' R&D spending was $20.6M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has iRhythm Holdings' R&D spending changed?
Over the last 7 quarters it ranged from $19.8M (Q2 2026) to $21.5M (Q1 2025).